Amubarvimab, previously known as BI 196, represents a significant advancement in therapeutic development, particularly concerning its ability to neutralize SARS-CoV-2 . This engineered antibody demonstrates https://opensocialfactory.com/story26249983/amubarvimab-a-in-depth-exploration-into-the-antibody-s-prospects